| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abdominal pain with anorexia in patients with breast carcinoma
|
Van Trappen, Ph.
|
|
|
9 |
11 |
p. 1243-1245
|
article
|
| 2 |
Abdominal pain with anorexia in patients with breast carcinoma
|
Ph. Van Trappen
|
|
1998
|
9 |
11 |
p. 1243-1245
3 p.
|
article
|
| 3 |
Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin’s lymphoma
|
Celsing, F.
|
|
|
9 |
11 |
p. 1213-1217
|
article
|
| 4 |
Addition of etoposide to CHOP chemotherapy in untreated patients withhigh-grade non-Hodgkins lymphoma
|
F. Celsing
|
|
1998
|
9 |
11 |
p. 1213-1217
5 p.
|
article
|
| 5 |
American pediatric merger spurns Europe
|
|
|
|
9 |
11 |
p. 1147
|
article
|
| 6 |
A phase III study of bi-weekly paclitaxel as first-line treatmentin metastatic breast cancer
|
K. A. Gelmon
|
|
1998
|
9 |
11 |
p. 1247-1249
3 p.
|
article
|
| 7 |
A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
|
Gelmon, K.A.
|
|
|
9 |
11 |
p. 1247-1249
|
article
|
| 8 |
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
|
Van Cutsem, E.
|
|
|
9 |
11 |
p. 1199-1204
|
article
|
| 9 |
A phase II study of irinotecan alternated with five days bolus of5-fluorouracil and leucovorin in first-line chemotherapy of metastaticcolorectal cancer
|
E. Van Cutsem
|
|
1998
|
9 |
11 |
p. 1199-1204
6 p.
|
article
|
| 10 |
A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer
|
Joel, S.
|
|
|
9 |
11 |
p. 1205-1211
|
article
|
| 11 |
A randomised, concentration-controlled, comparison of standard (5-day)vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lungcancer
|
S. Joel
|
|
1998
|
9 |
11 |
p. 1205-1211
7 p.
|
article
|
| 12 |
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
|
Makris, A.
|
|
|
9 |
11 |
p. 1179-1184
|
article
|
| 13 |
A reduction in the requirements for mastectomy in a randomized trial ofneoadjuvant chemoendocrine therapy in primary breast cancer
|
A. Makris
|
|
1998
|
9 |
11 |
p. 1179-1184
6 p.
|
article
|
| 14 |
A successful cancer march
|
|
|
|
9 |
11 |
p. 1146-1147
|
article
|
| 15 |
Awards, appointments
|
|
|
|
9 |
11 |
p. 1147-1148
|
article
|
| 16 |
Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
|
André, T.
|
|
|
9 |
11 |
p. 1251-1253
|
article
|
| 17 |
Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin(FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorinand 5-fluorouracil regimen
|
T. André
|
|
1998
|
9 |
11 |
p. 1251-1253
3 p.
|
article
|
| 18 |
Book review
|
Moulopoulos, L.A.
|
|
|
9 |
11 |
p. 1250
|
article
|
| 19 |
Book review
|
Laffer, U. Th.
|
|
|
9 |
11 |
p. 1150
|
article
|
| 20 |
Contents of the next issue
|
|
|
|
9 |
11 |
p. v
|
article
|
| 21 |
Copyright
|
|
|
|
9 |
11 |
p. iii
|
article
|
| 22 |
Critical reviews of economic analyses in order to make health care decisions for cancer
|
Neymark, N.
|
|
|
9 |
11 |
p. 1167-1172
|
article
|
| 23 |
Critical reviews of economic analyses in order to make health caredecisions for cancer
|
N. Neymark
|
|
1998
|
9 |
11 |
p. 1167-1172
6 p.
|
article
|
| 24 |
D. Buthiau, D. Khayat (eds), CT and MRI in oncology
|
L. A. Moulopoulos
|
|
1998
|
9 |
11 |
p. 1250-1250
1 p.
|
article
|
| 25 |
Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974–1994
|
Levi, F.
|
|
|
9 |
11 |
p. 1229-1232
|
article
|
| 26 |
Descriptive epidemiology of vulvar and vaginal cancers in Vaud,Switzerland, 19741994
|
F. Levi
|
|
1998
|
9 |
11 |
p. 1229-1232
4 p.
|
article
|
| 27 |
Editorial board
|
|
|
|
9 |
11 |
p. iv
|
article
|
| 28 |
Elderly patients with non-Hodgkin’s lymphoma: Population-based results in the Netherlands
|
Maartense, E.
|
|
|
9 |
11 |
p. 1219-1227
|
article
|
| 29 |
Elderly patients with non-Hodgkins lymphoma: Population-based resultsin the Netherlands
|
E. Maartense
|
|
1998
|
9 |
11 |
p. 1219-1227
9 p.
|
article
|
| 30 |
Gene therapy of malignant glioma: Recent advances in experimental and clinical studies
|
Sasaki, M.
|
|
|
9 |
11 |
p. 1155-1166
|
article
|
| 31 |
Gene therapy of malignant glioma: Recent advances in experimental andclinical studies
|
M. Sasaki
|
|
1998
|
9 |
11 |
p. 1155-1166
12 p.
|
article
|
| 32 |
In this Issue
|
|
|
|
9 |
11 |
p. v
|
article
|
| 33 |
J. G. Geraghty, J. M. Sackier, H. L. Young (eds), Minimal access surgeryin oncology
|
U. Th. Laffer
|
|
1998
|
9 |
11 |
p. 1150-1150
1 p.
|
article
|
| 34 |
NDDO splits from EORTC
|
|
|
|
9 |
11 |
p. 1145-1146
|
article
|
| 35 |
NDDO splits from EORTC; A successful cancer march; American pediatricmerger spurns Europe; Swiss calculate costs of smoking; Awards, appointments;Perhaps not everyone knows that...; Death toll: 5,000 children a month
|
|
|
1998
|
9 |
11 |
p. 1145-1149
5 p.
|
article
|
| 36 |
Perhaps not everyone knows that…
|
|
|
|
9 |
11 |
p. 1148-1149
|
article
|
| 37 |
Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study
|
Vansteenkiste, J.F.
|
|
|
9 |
11 |
p. 1193-1198
|
article
|
| 38 |
Potential use of FDG-PET scan after induction chemotherapy in surgicallystaged IIIaN2 non-small-cell lung cancer: A prospectivepilot study
|
J. F. Vansteenkiste
|
|
1998
|
9 |
11 |
p. 1193-1198
6 p.
|
article
|
| 39 |
Primary chemotherapy: A better overall therapeutic option for patients with breast cancer
|
Valero, V.
|
|
|
9 |
11 |
p. 1151-1154
|
article
|
| 40 |
Primary chemotherapy: A better overall therapeutic option for patientswith breast cancer
|
V. Valero
|
|
1998
|
9 |
11 |
p. 1151-1154
4 p.
|
article
|
| 41 |
Prognostic impact of an activation of coagulation in lung cancer
|
Watine, J.
|
|
|
9 |
11 |
p. 1255
|
article
|
| 42 |
Prognostic impact of an activation of coagulation in lung cancer
|
J. Watine
|
|
1998
|
9 |
11 |
p. 1255-1255
1 p.
|
article
|
| 43 |
Staging of breast cancer: What standards should be used in research and clinical practice?
|
Ravaioli, A.
|
|
|
9 |
11 |
p. 1173-1177
|
article
|
| 44 |
Staging of breast cancer: What standards should be used in research andclinical practice?
|
A. Ravaioli
|
|
1998
|
9 |
11 |
p. 1173-1177
5 p.
|
article
|
| 45 |
Swiss calculate costs of smoking
|
|
|
|
9 |
11 |
p. 1147
|
article
|
| 46 |
Table of Contents
|
|
|
|
9 |
11 |
p. ii-iii
|
article
|
| 47 |
This letter was referred to the author, who responds as follows:
|
Seitz, R.
|
|
|
9 |
11 |
p. 1255-1256
|
article
|
| 48 |
This letter was referred to the author, who responds as follows
|
R. Seitz
|
|
1998
|
9 |
11 |
p. 1255-1256
2 p.
|
article
|
| 49 |
Thoracic metastasectomy for germ cell tumours: Long term survival and prognostic factors
|
Cagini, L.
|
|
|
9 |
11 |
p. 1185-1191
|
article
|
| 50 |
Thoracic metastasectomy for germ-cell tumours: Long-term survival andprognostic factors
|
L. Cagini
|
|
1998
|
9 |
11 |
p. 1185-1191
7 p.
|
article
|
| 51 |
Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
|
Stupp, R.
|
|
|
9 |
11 |
p. 1233-1242
|
article
|
| 52 |
Ventricular arrhythmia and torsade de pointe: Dose limiting toxicitiesof the MDR-modulator S9788 in a phase I trial
|
R. Stupp
|
|
1998
|
9 |
11 |
p. 1233-1242
10 p.
|
article
|
Journal description